This well-conducted review concluded that antibiotic prophylaxis reduces the rate of surgical site infection by almost half in patients undergoing mesh inguinal hernioplasty. The authors' conclusions are likely to be reliable.
Participants included in the review
Studies of adults undergoing elective mesh inguinal hernioplasty, including those without contraindications to antibiotics, were eligible for inclusion. Studies of patients who were immunosuppressed due to disease or medication were excluded. The participants in the included studies had inguinal or groin hernia; some studies excluded patients with bilateral hernias and other excluded recurrent hernias.
Outcomes assessed in the review
Studies that assessed surgical site infection (SSI) as defined by the Center for Disease Control were eligible for inclusion.
How were decisions on the relevance of primary studies made? Two reviewers independently selected the studies and any disagreements were resolved by consensus.
Assessment of study quality
Validity was assessed using the following criteria described by the Cochrane Collaboration: randomisation, allocation concealment, blinded assessment of the outcomes, losses to follow-up, intention-to-treat analysis, description of statistical analysis, description of intervention, and clinical homogeneity.
Data extraction
Two reviewers independently extracted the data and any disagreements were resolved by consensus. For each study, the number of SSIs in the treatment and control groups were extracted.
